RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..9 of 9 - per page
Order by
Collagen-based biodegradable matrices for localized drug delivery More
Indicated for the treatment and prevention of diabetic foot ulcers. More
PsoriaVaTM incorporates calcipotriene 0.005%/betamethasone 0.64%) and the NexACT® technology. Pre-clinical studies have shown PsoriaVA® to deliver the same level of drugs as Taclonex with indication of superior safety profile. More
Topical NSAID Ibuprofen More
NexMed is developing RayVaTM, a topical treatment for Raynaud’s syndrome and incorporates alprostadil with the NexACT® proprietary permeation enhancer (DDAIP.HCL). More
a powerful Anti-Inflammatory pharmaceutical composition for use in established Allergic Contact Dermatitis More
MITI Systems has not only developed various prototypes of microneedles but also commercialized two types of polymer-based microneedle systems, Mi-Roll and Beauty Cap. More
Pacifier Pulse Oximeter Sensor: Use in Difficult to Monitor, Severely Burned Patients More
Displaying 1..9 of 9 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us